Home Team & Track Record Featured Companies  · Compass Pathways (CMPS)  · SpaceX (SPCX) AI-Assisted Portfolio Analysis Blog Contact Us Disclosure

Research Profiles

Featured Companies

Curated, compliance-reviewed stock profiles — each one thoroughly researched, vetted, and presented with full transparency so you can make informed decisions.

The Stock Sleuth — Wall Street Profit Search investigative research mascot

The Stock Sleuth

"Do the math..."
Filter:
Currently Featured

Compass Pathways Plc

NASDAQ: CMPS

Psychedelic Medicine · Clinical-Stage Biopharmaceuticals

The most advanced psychedelic-medicine company in the world — two successful Phase 3 trials, an active rolling NDA at the FDA, and a White House Executive Order accelerating the runway to commercial launch. Wall Street's mean target implies ~167% upside; the high target is a potential 7x.

  • Two successful Phase 3 trials of COMP360 synthetic psilocybin in treatment-resistant depression.
  • Rolling NDA filing at the FDA, with submission completion targeted for Q4 2026.
  • April 2026 White House Executive Order directing the FDA to accelerate psychedelic approvals.
  • Cash runway extends into 2028 — straight through commercial launch readiness.
View Full Profile
Open CMPS Portal →
Currently Featured

SpaceX

NASDAQ: SPCX

Space Launch & Satellite Internet · Newly Public

The largest IPO in history — SpaceX launches ~85% of everything the world puts into orbit and runs Starlink, the only profitable satellite-internet network on Earth. The stock now trades below its $135 IPO at ~$113, while a wave of buy-equivalent Street initiations put the consensus near $244.

  • Largest IPO ever: ~$75B raised at a ~$1.77T valuation (June 12, 2026).
  • Starlink: $11.4B in 2025 revenue at ~63% margins, 10.3M subscribers across 164 countries.
  • Now the most-shorted new stock on Wall Street — ~1/3 of the float — into first earnings (Aug 4).
  • A live Tesla–SpaceX merger question: one ticker for the whole Musk empire.
View Full Profile
Open SPCX Portal →

More Research

Other Reports & Track Record

Additional buy recommendations and our historical track record of past stock picks.

Current Pick

BLSH — Buy Recommendation

NYSE Cryptocurrency IPO · September 2025

Read the report →

Track Record Archive